References
- Korea Central Cancer Registry, National Cancer Center. Annual report of cancer statistics in Korea in 2014 [Internet]. Sejong: Ministry of Health and Welfare; 2016 [cited 2017 Apr 25]. Available from: http://ncc.re.kr/main.ncc?uri= english/sub04_Statistics.
- Antman KH, Blum RH, Greenberger JS, Flowerdew G, Skarin AT, Canellos GP. Multimodality therapy for malignant mesothelioma based on a study of natural history. Am J Med 1980;68:356-62. https://doi.org/10.1016/0002-9343(80)90103-5
- Treasure T, Lang-Lazdunski L, Waller D, et al. Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study. Lancet Oncol 2011;12:763-72. https://doi.org/10.1016/S1470-2045(11)70149-8
- Flores RM, Pass HI, Seshan VE, et al. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 2008;135: 620-6,626.e1-3. https://doi.org/10.1016/j.jtcvs.2007.10.054
- Batirel HF, Metintas M, Caglar HB, et al. Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy. J Thorac Cardiovasc Surg 2016;151:478-84. https://doi.org/10.1016/j.jtcvs.2015.09.121
- Byrne MJ, Nowak AK. Modified RECIST criteria for assessment of response in malignant pleural mesothelioma. Ann Oncol 2004;15:257-60. https://doi.org/10.1093/annonc/mdh059
- National Comprehensive Cancer Network. Malignant pleural mesothelioma: version 1 [Internet]. Fort Washington (PA): National Comprehensive Cancer Network; 2017 [cited 2017 Jun 2]. Available from: https://www.nccn.org/professionals/physician_gls/pdf/mpm.pdf.
- Butchart EG, Ashcroft T, Barnsley WC, Holden MP. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura. Experience with 29 patients. Thorax 1976;31:15-24. https://doi.org/10.1136/thx.31.1.15
- Sugarbaker DJ, Flores RM, Jaklitsch MT, et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 1999;117:54-63. https://doi.org/10.1016/S0022-5223(99)70469-1
- Rusch VW, Rosenzweig K, Venkatraman E, et al. A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 2001;122:788-95. https://doi.org/10.1067/mtc.2001.116560
- Infante M, Morenghi E, Bottoni E, et al. Comorbidity, postoperative morbidity and survival in patients undergoing radical surgery for malignant pleural mesothelioma. Eur J Cardiothorac Surg 2016;50:1077-82. https://doi.org/10.1093/ejcts/ezw215
- Hasegawa S, Okada M, Tanaka F, et al. Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan Mesothelioma Interest Group 0601 Trial). Int J Clin Oncol 2016;21: 523-30. https://doi.org/10.1007/s10147-015-0925-1
- Martini N, Bains MS, Beattie EJ Jr. Indications for pleurectomy in malignant effusion. Cancer 1975;35:734-8. https://doi.org/10.1002/1097-0142(197503)35:3<734::AID-CNCR2820350328>3.0.CO;2-N
- Cao C, Tian D, Park J, Allan J, Pataky KA, Yan TD. A systematic review and meta-analysis of surgical treatments for malignant pleural mesothelioma. Lung Cancer 2014; 83:240-5. https://doi.org/10.1016/j.lungcan.2013.11.026
- Rusch VW, Giroux D, Kennedy C, et al. Initial analysis of the international association for the study of lung cancer mesothelioma database. J Thorac Oncol 2012;7:1631-9. https://doi.org/10.1097/JTO.0b013e31826915f1
- Rusch VW. Pleurectomy/decortication and adjuvant therapy for malignant mesothelioma. Chest 1993;103(4 Suppl): 382S-384S. https://doi.org/10.1378/chest.103.4_Supplement.382S
- Waller DA, Dawson AG. Randomized controlled trials in malignant pleural mesothelioma surgery-mistakes made and lessons learned. Ann Transl Med 2017;5:240. https://doi.org/10.21037/atm.2017.04.05
- Vogelzang NJ, Rusthoven JJ, Symanowski J, et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol 2003;21:2636-44. https://doi.org/10.1200/JCO.2003.11.136
- Stahel RA, Riesterer O, Xyrafas A, et al. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial. Lancet Oncol 2015;16:1651-8. https://doi.org/10.1016/S1470-2045(15)00208-9
- Takuwa T, Hasegawa S. Current surgical strategies for malignant pleural mesothelioma. Surg Today 2016;46:887-94. https://doi.org/10.1007/s00595-015-1275-3
Cited by
- Erratum: Outcomes of the Multimodal Treatment of Malignant Pleural Mesiothelioma: The Role of Surgery vol.51, pp.2, 2018, https://doi.org/10.5090/kjtcs.2018.51.2.159